You may be eligible to enroll as a research participant in a clinical trial study for new and exciting treatments and medications.

Atopic Dermatitis - moderate to severe - IN ADULTS

Purpose of the study: to evaluate the long-term safety, tolerability and efficacy of subcutaneous amlitelimab in adult participants with moderate to severe atopic dermatitis.

​

For more information please email research@saskatoondermatology.ca